How to Test Retatrutide: Identity, Purity and Content

To test retatrutide, send a sealed vial to an independent lab that measures three things against a reference standard: identity, chromatographic purity and net-peptide content in mg per vial. At KMD Analytical, an independent third-party peptide testing lab in Chatsworth, California, we test mail-in vials by RP-HPLC-UV. We do not sell peptides and have no stake in any result. Each certificate is sealed and can be checked at kmdanalytical.com/verify.
This guide is for vendors, manufacturers, researchers, buyers checking a certificate of analysis (COA) and people organizing a group test. It covers what a retatrutide test measures, how to submit a vial, what it costs and how to read the result.
Summary
- A proper retatrutide test reports three separate results: identity (retention-time and UV-spectral match against a reference standard), chromatographic purity (area %) and net-peptide content (mg per vial).
- Purity alone does not tell you how much peptide is in the vial. Content in mg is the number that answers that.
- Our turnaround is 5–7 business days typical, 7 maximum. Vial testing costs $150 per vial for 1–4 vials, $125 for 5–9 and $100 for 10 or more.
- A certificate describes the submitted sample only. It is not an endorsement of a product and not a statement about safety.
- Each of our certificates carries a unique ID, a QR code and a SHA-256 seal, so anyone can confirm it is genuine.
Table of Contents
- What a retatrutide test actually measures
- Our method, in plain terms
- How to submit a retatrutide vial
- What testing costs
- How to read a retatrutide COA
- The regulatory context
- Our view: purity is the number everyone quotes, content is the one that matters
- Get a retatrutide vial tested
- FAQ
- Sources
What a retatrutide test actually measures
Retatrutide is an investigational molecule. According to Eli Lilly’s medical information page, it cannot be legally sold or marketed for human use. That is the regulatory backdrop, and it is the reason analytical documentation matters to anyone who handles the compound for research or manufacturing: there is no approved product label to rely on, so the vial’s contents are only as credible as the testing behind them.
A test answers three questions, and each needs its own measurement.
Identity: is it the right molecule?
Identity means the main peak in the sample behaves like a known reference standard of the same compound. In our method, identity equals a retention-time match plus a UV-spectral match against that reference standard. Retention time is how long the compound takes to travel through the chromatography column. The UV spectrum is the pattern of light the compound absorbs, captured by a diode-array detector. When both match the standard, the peak is the compound you expect. When they do not, the label is in question before purity even matters. Our guide on how peptide identity is confirmed on a COA walks through this in more detail.
Chromatographic purity: how much of the signal is the target?
Purity by HPLC is reported as area %: the area of the main peak divided by the total area of all peaks detected. Imagine a chromatogram as a bar chart of everything the detector saw. A purity of 98% means the target peak accounts for 98% of that detected signal.
Two cautions apply when you compare purity figures. First, area % is method-dependent: column, mobile phase, gradient, detection wavelength and integration choices all shift the number, which is why a company explanation of COA purity stresses that figures from different methods are hard to compare. Second, area % says nothing about how much peptide is physically in the vial. It describes proportions of what was detected, not quantity.

Net-peptide content: how much is actually there?
This is the number most often missing from a COA. Net-peptide content is reported in mg per vial. A lyophilized (freeze-dried) vial holds more than peptide: it can also contain moisture, counter-ions and excipients. A vial labeled with a given amount can therefore be 99% pure by area and still contain well under the labeled quantity of peptide.
The gap between purity and content is the single most important thing to understand when you read a certificate. Our content spec is at least 90% of the label claim, with no upper cap. A result above the label claim is reported as measured, not truncated.
Our method, in plain terms
We use reversed-phase HPLC with UV diode-array detection (RP-HPLC-UV) on an Agilent HPLC-DAD, with quantitation at 214 nm. That wavelength is where the peptide bond absorbs, so it responds to the peptide backbone itself rather than to a particular side chain.
Every certificate reports:
- Identity, by retention-time and UV-spectral match against a reference standard.
- Chromatographic purity, in area %.
- Net-peptide content, in mg per vial.
Blends are handled differently from single-compound vials. Each active is reported on its own row on one certificate, and a blend never gets a single purity number, because one figure would hide which component is carrying the impurities.
How to submit a retatrutide vial
The process is short, and most delays come from missing information rather than from the lab. For a general overview, see how third-party peptide testing works.
Step 1: Decide what you need measured
For most retatrutide submissions the standard package is identity, purity and net-peptide content, which is what our peptide testing service covers in one run. Our retatrutide testing page lists the specifics for this compound. If the vial is a blend, tell us every active so each gets its own row.
Two add-ons come up often:
- Bacterial endotoxin testing uses USP <85> kinetic chromogenic LAL and reports a result in EU/mL. It costs $150 per vial. It is not a sterility test: it measures bacterial endotoxin, not whether living organisms are present. Details are on our endotoxin page.
- Solution pH is $20 and bacteriostatic water testing is $75. Both are listed on the pricing page.
Step 2: Record the label claim and batch details
Content is judged against the label claim, so write down the stated amount per vial exactly as printed, along with the product name, batch or lot number and the source. Without a label claim there is nothing to measure content against, and without a lot number a result cannot be tied back to a batch later.
Step 3: Mail the vial
We test mail-in vials. Send the vial as you received it, in its original container, so the result reflects what was actually sold. Opening, splitting or re-packaging a vial before it arrives changes what the lab can say about it. A certificate reports what was in the submitted sample, so the cleaner the chain from purchase to lab, the more the result means.
Step 4: Choose your timeline
Turnaround is 5–7 business days typical, with 7 as the maximum. If you need it faster, rush returns results the next business day. Rush is a +100% surcharge, is limited to up to 4 vials, and vials must be received by 12:00 PT. Same-day service exists by arrangement only, at +150%, with vials received by 10:00 AM PT. It is not available on the order form.
Step 5: Receive and verify the certificate
The certificate arrives sealed with a SHA-256 hash, a unique ID and a QR code. Anyone can enter the ID or scan the code at kmdanalytical.com/verify to confirm the document is genuine and unaltered. If you are a vendor, that means your customers can check your certificate without calling you.
What testing costs
Prices are per vial and drop with volume:
| Vials in the order | Price per vial |
|---|---|
| 1–4 | $150 |
| 5–9 | $125 |
| 10 or more | $100 |
Blends add 50% per active beyond the first. Rush adds 100% per order. Endotoxin testing is $150 per vial. The full list is on our pricing page.
A worked example for group organizers. Say ten members each want a different vial of retatrutide checked. Four vials ordered alone would cost $600 in total, at $150 each. Ten vials ordered together cost $1,000, at $100 each, so each member’s share drops from $150 to $100. Splitting a single order is the practical way to reach the lower tiers, and it also gives the group one consistent method across every vial, which makes the results comparable.

How to read a retatrutide COA
Whether the certificate is ours or someone else’s, read it in this order.
- Does it state the method? A purity figure with no method behind it cannot be compared with anything. Look for the technique, detector and wavelength.
- Is identity tied to a reference standard? A statement that identity was “confirmed” is weaker than a stated match against a standard.
- Is there a content figure in mg? If the certificate gives only purity, you know proportions but not quantity.
- Is the result tied to the batch? Check that the lot number, the date and the stated sample match the vial in your hand.
- Can you verify it independently? A certificate with a unique ID that a third party can check is harder to alter or invent than a PDF alone. Our guide on how to verify a peptide COA and spot a fake covers the common signs of a doctored document.
- Who produced it? A lab that also sells the peptide has an interest in the outcome. An independent lab that sells no peptides does not. If you are weighing options, where to get peptides tested lays out the types of lab and what to compare.
What a certificate does not say
A certificate reports analytical results on the submitted sample only. It does not endorse a product, and it is not a statement about safety. It also speaks only for the vial tested: a second vial from the same lot is a separate sample. Vendors who want to demonstrate consistency across a lot or across lots can use batch testing for vendors and brands or set up an ongoing testing program.
The regulatory context
Handling a compound that has no approved status raises the stakes on documentation. The FDA states in its alert on unapproved GLP-1 drugs that retatrutide cannot be used in compounding under federal law, because it is not a component of an FDA-approved drug. A letter from the FDA relayed to state pharmacy boards dated April 3, 2025 gives the reasoning: it does not appear on the 503A or 503B bulks lists and has no USP/NF monograph.
The classification question is also moving. As reported by On The Pen, on October 2, 2026 the FDA restated on remand that retatrutide is not a biological product, since its chain has 39 alpha amino acids, below the 40-amino-acid threshold. The same report notes this is a dispute over classification, not a rejection of the drug, and that the appeal remained pending. For a broader view of the trial status and evidence gaps, see this overview of retatrutide trial-only evidence gaps.
None of this changes what a laboratory test does. It measures the contents of a sample. It does not tell anyone how a compound should be used, and we do not give dosing, reconstitution or use guidance of any kind. We also do not test controlled substances, HGH/somatropin, testosterone or steroids, or SARMs.
Our view: purity is the number everyone quotes, content is the one that matters
Most retatrutide COAs a buyer meets lead with a purity percentage. It is an easy number to print and a hard one to compare, because it depends on the method behind it.
We built our certificate around three results because each one catches a different failure. Identity catches the wrong molecule. Purity catches a contaminated one. Net-peptide content in mg per vial catches the vial that is pure but under-filled. A document that reports only one of them leaves the other two failures invisible.
Because we do not sell peptides, no result helps us. A vendor with a good lot gets a certificate that says so, and one with a problem gets that on the certificate too. Sealing each certificate with a SHA-256 hash and a QR code means that whoever you hand it to can check it without trusting either of us.
kevin
Get a retatrutide vial tested
If you are a vendor proving what is in each vial, a researcher who needs accurate compound analysis, or a buyer who wants a vendor’s claim checked, our testing runs from $100 to $150 per vial with 5–7 business days typical turnaround.

See current pricing and order on the KMD Analytical pricing page, or start from the retatrutide testing page. For method development or ongoing programs, contact us through kmdanalytical.com.
FAQ
Can you test retatrutide for identity and purity at the same time?
Yes. Every certificate reports identity, chromatographic purity (area %) and net-peptide content (mg per vial) from the same submission. Identity is a retention-time and UV-spectral match against a reference standard. Purity and content come from the same RP-HPLC-UV analysis, quantitated at 214 nm.
Does a high purity number mean the vial contains the labeled amount?
No. Purity is the target peak’s share of the detected signal, while content is how many mg of peptide are in the vial. A vial can be highly pure and still hold less than its label states. Our content spec is at least 90% of label claim with no upper cap, which is why we report both numbers.
Is endotoxin testing the same as sterility testing?
No. Endotoxin testing by USP <85> kinetic chromogenic LAL reports endotoxin in EU/mL, at $150 per vial. It is not a sterility test and does not show whether living organisms are present.
How fast can I get results?
Typical turnaround is 5–7 business days, with 7 as the maximum. Rush gives next-business-day results for a +100% surcharge, limited to up to 4 vials received by 12:00 PT.
Can anyone confirm my certificate is real?
Yes. Each certificate is sealed with a SHA-256 hash and carries a unique ID and QR code. Anyone can check it at kmdanalytical.com/verify.
Sources
- Is retatrutide available in the consumer market? (Eli Lilly medical information)
- FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
- FDA letter on retatrutide in compounded drug products (state boards of pharmacy)
- FDA reiterates retatrutide is not a biologic (On The Pen)
- Retatrutide Certificate of Analysis: HPLC Purity Explained
Recommended
- Retatrutide Testing | Identity & Purity
- Retatrutide / Cagrilintide Blend Testing
- Tirzepatide (LY3298176) Testing
- How Peptide Identity Is Confirmed on a COA
KMD Analytical reports analytical results on submitted samples only. Nothing here is medical advice or a statement that any product is safe or suitable for use.